Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|December 14, 1999
Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardiumR Padrini, M Panfili, G Magnolfi, et al.
Clinical Pharmacology and Therapeutics|January 1, 1993
Pharmacodynamic variability of flecainide assessed by QRS changesR Padrini, D Piovan, M Busa, et al.
Giornale Italiano Di Cardiologia|July 1, 1989
[Variations in left ventricular function during chronic therapy with verapamil in angina patients. Influence of the plasma concentration of the drug. Quantitative M-mode echocardiographic analysis]L Zanolla, P Marino, G Golia, et al.
International Journal of Clinical Pharmacology Research|January 1, 1985
Plasma levels and urinary excretion of verapamil, norverapamil, N-dealkylverapamil (D617), N-dealkylnorverapamil (D620) following oral administration of a slow-release preparationE Barbieri, R Padrini, D Piovan, et al.
Pharmacological Research|May 1, 1997
Adaptation of the QT interval to heart rate changes in isolated perfused guinea pig heart: influence of amiodarone and D-sotalolR Padrini, G Speranza, G Nollo, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Verapamil pharmacokinetics and liver function in patients with cirrhosisG F Finucci, R Padrini, D Piovan, et al.
British Journal of Clinical Pharmacology|September 1, 1988
The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosisC Merkel, A Gatta, M Bolognesi, et al.
Journal of Cardiovascular Pharmacology|May 1, 1984
Long-term persistence of antianginal effect of oral verapamil in chronic stable anginaL Zanolla, G P Trevi, A Rizzo, et al.
Cardiologia (Rome, Italy)|May 1, 1989
[Pharmacodynamics and pharmacokinetics of flecainide in cardiac pre-excitation of the bundle of Kent]E Casiglia, R Padrini, D Piovan, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in manR Padrini, E Barbieri, D Piovan, et al.
Pageof 7